-
1
-
-
0035901331
-
Acide arachidonique et prostaglandines, inflammation et oncologie
-
Eschwège P, de Ledinghen V, Camilli T, et al: Arachidonic acid and prostaglandins, inflammation and oncology. Presse Med 30: 508-510, 2001 (In French). (Pubitemid 32238359)
-
(2001)
Presse Medicale
, vol.30
, Issue.10
, pp. 508-510
-
-
Eschwege, P.1
De Ledinghen, V.2
Camilli, T.3
Kulkarni, S.4
Dalbagni, G.5
Droupy, S.6
Jardin, A.7
Benoit, G.8
Weksler, B.B.9
-
2
-
-
84863024994
-
Expression of hTERT and its correlation with expression of P-gp, COX-2, Bcl-2 and the clinical pathological features of patients with pancreatic cancer
-
Zhong YQ, Shen XM, Li HG, et al: Expression of hTERT and its correlation with expression of P-gp, COX-2, Bcl-2 and the clinical pathological features of patients with pancreatic cancer. Zhonghua Linchuang Yishi Zazhi 2: 14-18, 2008.
-
(2008)
Zhonghua Linchuang Yishi Zazhi
, vol.2
, pp. 14-18
-
-
Zhong, Y.Q.1
Shen, X.M.2
Li, H.G.3
-
3
-
-
77954091914
-
Knockdown of hTERT by siRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2
-
Zhong YQ, Xia ZS, Fu YR, et al: Knockdown of hTERT by siRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2. J Dig Dis 11: 176-184, 2010.
-
(2010)
J Dig Dis
, vol.11
, pp. 176-184
-
-
Zhong, Y.Q.1
Xia, Z.S.2
Fu, Y.R.3
-
4
-
-
84863079816
-
Effect of silencing expression of hTERT gene by siRNA on the expression of Bcl-2 and COX-2 genes of human pancreatic cancer cells in vitro
-
Zhong YQ, Huang HR, Fu YR, et al: Effect of silencing expression of hTERT gene by siRNA on the expression of Bcl-2 and COX-2 genes of human pancreatic cancer cells in vitro. Zhonghua Linchuang Yishi Zazhi 4: 34-38, 2010.
-
(2010)
Zhonghua Linchuang Yishi Zazhi
, vol.4
, pp. 34-38
-
-
Zhong, Y.Q.1
Huang, H.R.2
Fu, Y.R.3
-
5
-
-
0036006453
-
2, transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
-
DOI 10.1038/nm0302-289
-
Pai R, Soreghan B, Szabo IL, et al: Prostaglandin E2 trans- activates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8: 289-293, 2002. (Pubitemid 34250108)
-
(2002)
Nature Medicine
, vol.8
, Issue.3
, pp. 289-293
-
-
Pai, R.1
Soreghan, B.2
Szabo, I.L.3
Pavelka, M.4
Baatar, D.5
Tarnawski, A.S.6
-
6
-
-
0037169557
-
2
-
DOI 10.1074/jbc.M109440200
-
Fujino H, West KA and Regan JW: Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 277: 2614-2619, 2002. (Pubitemid 34953286)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.4
, pp. 2614-2619
-
-
Fujino, H.1
West, K.A.2
Regan, J.W.3
-
7
-
-
0036296869
-
2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway
-
DOI 10.1006/bbrc.2001.6188
-
Liu XH, Kirschenbaum A, Lu M, et al: Prostaglandin E (2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophys Res Commun 290: 249-255, 2002. (Pubitemid 34694491)
-
(2002)
Biochemical and Biophysical Research Communications
, vol.290
, Issue.1
, pp. 249-255
-
-
Liu, X.-H.1
Kirschenbaum, A.2
Lu, M.3
Yao, S.4
Klausner, A.5
Preston, C.6
Holland, J.F.7
Levine, A.C.8
-
8
-
-
0037757694
-
2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells
-
DOI 10.1016/S0006-291X(03)01079-9
-
Eibl G, Bruemmer D, Okada Y, et al: PGE (2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochem Biophys Res Commun 306: 887-897, 2003. (Pubitemid 36776213)
-
(2003)
Biochemical and Biophysical Research Communications
, vol.306
, Issue.4
, pp. 887-897
-
-
Eibl, G.1
Bruemmer, D.2
Okada, Y.3
Duffy, J.P.4
Law, R.E.5
Reber, H.A.6
Hines, O.J.7
-
9
-
-
5644220189
-
2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2
-
DOI 10.1158/0008-5472.CAN-04-1177
-
Ito H, Duxbury M, Benoit E, et al: Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res 64: 7439-7446, 2004. (Pubitemid 39372086)
-
(2004)
Cancer Research
, vol.64
, Issue.20
, pp. 7439-7446
-
-
Ito, H.1
Duxbury, M.2
Benoit, E.3
Clancy, T.E.4
Zinner, M.J.5
Ashley, S.W.6
Whang, E.E.7
-
10
-
-
33645665983
-
Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer
-
Juuti A, Louhimo J, Nordling S, et al: Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol 59: 382-386, 2006.
-
(2006)
J Clin Pathol
, vol.59
, pp. 382-386
-
-
Juuti, A.1
Louhimo, J.2
Nordling, S.3
-
11
-
-
33644550286
-
Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray
-
Xu L, Li YM, Yu CH, et al: Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray. Hepatobiliary Pancreat Dis Int 5: 138-142, 2006.
-
(2006)
Hepatobiliary Pancreat Dis Int
, vol.5
, pp. 138-142
-
-
Xu, L.1
Li, Y.M.2
Yu, C.H.3
-
12
-
-
0033106051
-
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
-
Tucker ON, Dannenberg AJ, Yang EK, et al: Cyclooxygenase-2 expression is upregulated in human pancreatic cancer. Cancer Res 59: 987-990, 1999. (Pubitemid 29135954)
-
(1999)
Cancer Research
, vol.59
, Issue.5
, pp. 987-990
-
-
Tucker, O.N.1
Dannenberg, A.J.2
Yang, E.K.3
Zhang, F.4
Teng, L.5
Daly, J.M.6
Soslow, R.A.7
Masferrer, J.L.8
Woerner, B.M.9
Koki, A.T.10
Fahey III, T.J.11
-
13
-
-
0033859744
-
Blockade of cyclooxygenase- 2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells
-
Ding XZ, Tong WG and Adrian TE: Blockade of cyclooxygenase- 2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res 20: 2625-2631, 2000.
-
(2000)
Anticancer Res
, vol.20
, pp. 2625-2631
-
-
Ding, X.Z.1
Tong, W.G.2
Adrian, T.E.3
-
14
-
-
14644420887
-
Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer
-
DOI 10.1158/1078-0432.CCR-04-1696
-
Yao M, Zhou W, Sangha S, et al: Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth,angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res 11: 1618-1628, 2005. (Pubitemid 40315247)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.4
, pp. 1618-1628
-
-
Yao, M.1
Zhou, W.2
Sangha, S.3
Albert, A.4
Chang, A.J.5
Liu, T.C.6
Wolfe, M.M.7
-
15
-
-
1642369791
-
Effect of a Selective Cyclooxygenase-2 Inhibitor, Nimesulide, on the Growth of Lung Tumors and Their Expression of Cyclooxygenase-2 and Peroxisome Proliferator-Activated Receptor-gamma
-
DOI 10.1158/1078-0432.CCR-0902-03
-
Shaik MS, Chatterjee A and Singh M: Effect of a selective Cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma. Clin Cancer Res 10: 1521-1529, 2004. (Pubitemid 38365248)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.4
, pp. 1521-1529
-
-
Shaik, M.S.1
Chatterjee, A.2
Singh, M.3
-
16
-
-
77953425618
-
Therapeutic effect of different doses of celecoxib on human lung cancer xenograft in nude mice and its action mechanism
-
Chen G and Duan HJ: Therapeutic effect of different doses of celecoxib on human lung cancer xenograft in nude mice and its action mechanism. Tumor 28: 837-841, 2008.
-
(2008)
Tumor
, vol.28
, pp. 837-841
-
-
Chen, G.1
Duan, H.J.2
-
17
-
-
19744380776
-
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
-
DOI 10.1056/NEJMoa050493
-
Bresalier RS, Sandler RS, Quan H, et al: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemo- prevention trial. N Engl J Med 352: 1092-1102, 2005. (Pubitemid 40365350)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.11
, pp. 1092-1102
-
-
Bresalier, R.S.1
Sandler, R.S.2
Quan, H.3
Bolognese, J.A.4
Oxenius, B.5
Horgan, K.6
Lines, C.7
Riddell, R.8
Morton, D.9
Lanas, A.10
Konstam, M.A.11
Baron, J.A.12
|